Chrysanthevelides A−D, the Rearranged 5/5/5 Tricyclic Spiro-Guaianolides and 1, 3-Dioxolane-Containing Nor-Guaianolide Dimers from Chrysanthemum vestitum Target PKM2 to Mediate the Anti-Inflammatory Effect
Journal of Natural Products · 2026
DOI: 10.1021/acs.jnatprod.6c00889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2026. Verfasst von Gui-Min Xue und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou450046, China. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Chrysanthemum, Sesquiterpenes, Guaiane, Carrier Proteins. Die Arbeit nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Henan Province, Natural Science Foundation of Tianjin City.
Abstract (Originalsprache)
Four unprecedented dimeric (1−2) and monomeric (3−4) sesquiterpenoids were isolated from the aerial part of Chrysanthemum vestitum. Chrysanthevelides A−B (1−2) represented the first example of the dimers with a special 1,3-dioxolane nor-guaianolide sesquiterpenoid unit, while chrysanthevelides C−D (3−4) were two pairs of unprecedented 1,10-seco rearranged 5/5/5 tricyclic spiro-guaianolide sesquiterpenoids. The undescribed structures of 1−4, including their absolute configurations, were determined through spectroscopic techniques combined with DP4+ NMR analysis and ECD calculations. Compound 1 displayed an NO production inhibitory effect with an IC50 value of 1.62 ± 0.21 μM. Primarily, western blotting and ELISA combined with the RNA-seq results indicated that 1 suppressed downstream-related inflammatory factors (IL-6 and TNF-α) and proteins (COX-2 and iNOS). Mechanistically, the α-methylene-γ-lactone (αMγL) moiety of 1 covalently binds to Cys423 of PKM2, promoting its tetramerization, which in turn regulates the HIF-1α/STAT3 axis and the glycolytic pathway. This ultimately suppressed the expression of inflammatory mediators, thereby achieving its anti-inflammatory function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou450046, China.
- Henan Collaborative Innovation Center for Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou450046, China.
- School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin300384, China.
- The Affiliated Taizhou Second People's Hospital of Yangzhou University, Taizhou225500, China.
ORCID-Profile: Gui-Min Xue, Hui Chen, Yan-Le Zhi
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Henan Province
- Natural Science Foundation of Tianjin City
- Education Department of Henan Province
- Science and Technology Department of Henan Province
Zitieren
APA
Xue, G. M., Guo, X. X., Li, Y. J., Feng, H., Zhu, D. R., Chen, H., Sun, Y. J., Zhi, Y. L., Li, G. S., & Xue, J. F. (2026). Chrysanthevelides A−D, the Rearranged 5/5/5 Tricyclic Spiro-Guaianolides and 1, 3-Dioxolane-Containing Nor-Guaianolide Dimers from Chrysanthemum vestitum Target PKM2 to Mediate the Anti-Inflammatory Effect. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.6c00889
Vancouver
Xue GM, Guo XX, Li YJ, Feng H, Zhu DR, Chen H, et al. Chrysanthevelides A−D, the Rearranged 5/5/5 Tricyclic Spiro-Guaianolides and 1, 3-Dioxolane-Containing Nor-Guaianolide Dimers from Chrysanthemum vestitum Target PKM2 to Mediate the Anti-Inflammatory Effect. Journal of Natural Products. 2026. doi:10.1021/acs.jnatprod.6c00889
BibTeX
@article{Xue2026,
author = {Xue, Gui-Min and Guo, Xin-Xin and Li, Yan-Jie and Feng, Hao and Zhu, Dong-Rong and Chen, Hui and Sun, Yan-Jun and Zhi, Yan-Le and Li, Guo-Sheng and Xue, Jin-Feng},
title = {Chrysanthevelides A−D, the Rearranged 5/5/5 Tricyclic Spiro-Guaianolides and 1, 3-Dioxolane-Containing Nor-Guaianolide Dimers from Chrysanthemum vestitum Target PKM2 to Mediate the Anti-Inflammatory Effect},
journal = {Journal of Natural Products},
year = {2026},
doi = {10.1021/acs.jnatprod.6c00889}
}
EUVIMED